But the TACE-RFA group did not disclose the same outcomes of OS for patients with tumor >3 cm and patients with more than one tumor with the P value being borderline significant.
← all excerpts
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma.
1
—
—